WASHINGTON, March 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it willparticipate at the following upcoming investor conferences in March 2017.
The Cowen and Company 37th Annual Healthcare Conference in Boston on Tuesday,
The Oppenheimer 27th Annual Healthcare Conference in New York City on Tuesday, March 21, 2017. A corporate presentation is scheduled for 10:20 a.m. Eastern Time.
The corporate presentations given at the Cowen and Oppenheimer conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim KellyExecutive Vice President and Chief Financial OfficerVanda Pharmaceuticals Inc.(202) firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-march-2017-investor-conferences-300418636.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All